Hui Lia,
Yi Lib,
Xiao-Bing Wanga,
Tao Pangc,
Lu-Yong Zhangc,
Jun Luo*a and
Ling-Yi Kong*a
aState Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, People's Republic of China. E-mail: cpu_lykong@126.com; luojun1981ly@163.com; Fax: +86-25-8327-1405; Tel: +86-25-8327-1405
bTesting & Analysis Center, Nanjing Normal University, Nanjing 210046, People's Republic of China
cJiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, People's Republic of China
First published on 27th April 2015
Fourteen new mexicanolide-type limonoids, khasenegasins A–N (1–14), together with three known limonoids (15–17) were isolated from the seeds of Khaya senegalensis (Desr.) A. Juss. Their structures were elucidated on the basis of NMR, HRMS and single crystal diffraction techniques. The absolute configuration of compound 1 was determined by single-crystal X-ray diffraction using mirror Cu Kα radiation. Two of the compounds (6 and 17) displayed in vitro neuroprotective activities against glutamate-induced injury in primary rat cerebellar granule neuronal cells (CGCs) at a concentration of 10 μM and 1 μM.
As a result, 14 new compounds (1–14) (Fig. 1), as well as 3 known compounds (15–17) were obtained from the ethanol (95%) extract. Their structures were elucidated by extensive 1D and 2D NMR (HSQC, HMBC, and ROESY) and mass (HRESIMS) spectroscopic data analysis. The absolute configuration of compound 1 was determined by a single-crystal X-ray diffraction experiment, and the similar electronic circular dichroism spectra of 1–9 indicated that the basic skeletons of these compounds possessed consistent absolute configurations. All the isolates except 1, 11 and 16, which were obtained in a limited amount, were evaluated for the neuroprotective activities against glutamate-induced injury in primary rat cerebellar granule neuronal cells at 10 μM, showing protective actions. Herein, we report the isolation, structure elucidation of compounds 1–14 and neuroprotective activities of main compounds.
Khasenegasin A (1) was obtained as a white powder, and was recrystallized as colorless crystals in CH2Cl2–MeOH (1:1), which had a molecular formula of C31H38O11 established by HRESIMS at m/z 609.2304 ([M + Na]+, C31H38O11Na, calcd 609.2306). In the 1H and 13C NMR spectra (Table 1), the presence of three characteristic olefinic proton signals at δH 6.63, 7.43 and 7.85, four olefinic carbons at δC 110.0, 120.0, 142.2 and 142.8 indicated that compound 1 possessed a β-substituted furan. The 1H NMR spectrum showed the presence of the characteristic H-17 singlet at δH 5.61, four methyl singlets at δH 0.97 (Me-18), 1.26 (Me-19), 0.77 (Me-28), and 0.79 (Me-29), and a methoxy singlet (δH 3.72). An olefinic proton signal was observed at δH 5.77 (dd, J = 7.0, 2.5 Hz, H-30). In addition, the 13C NMR spectrum indicated the presence of two carbonyls belonging to a cyclohexanone at δC 215.5 (C-1) and a lactone at δC 168.3 (C-16), two olefinic carbon signals at δC 139.5 (C-8) and δC 127.4 (C-30). The aforementioned data suggested that 1 was a mexicanolide-type limonoid with a Δ8,30 double bond.17
Position | 1 | 2 | 3 | 4 | 5 | |||||
---|---|---|---|---|---|---|---|---|---|---|
δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | |
1 | 215.5 | 218.0 | 216.6 | 218.0 | 216.8 | |||||
2 | 3.54, m | 48.6 | 3.41, m | 51.3 | 3.50, m | 48.6 | 3.37, td (9.0, 1.5) | 51.3 | 3.44, dd (9.0, 5.5) | 51.0 |
3 | 4.80, d (9.5) | 77.4 | 3.78, d (9.3) | 76.5 | 4.78, d (9.5) | 77.7 | 3.81, d (9.0) | 76.9 | 3.80, d (9.0) | 77.8 |
4 | 38.4 | 39.9 | 38.3 | 40.0 | 40.0 | |||||
5 | 3.40, d (10.0) | 41.2 | 3.38, d (10.4) | 40.2 | 3.33, dd (7.5, 4.0) | 41.6 | 3.30, dd (8.0, 4.0) | 40.5 | 3.24, dd (9.5, 1.7) | 39.2 |
6 | 2.35, dd (17.5, 10.0) | 32.6 | 2.33, dd (17.3, 10.4) | 32.9 | 2.38, d (7.5) | 33.1 | 2.37, d (8.0) | 33.3 | 2.31, dd (17.2, 1.7) | 32.9 |
2.19, d (17.5) | 2.18, d (17.3) | 2.37, d (4.0) | 2.36, d (4.0) | 2.37, dd (17.2, 9.5) | ||||||
7 | 173.5 | 173.8 | 174.2 | 174.2 | 174.8 | |||||
8 | 139.5 | 137.9 | 141.2 | 140.5 | 142.3 | |||||
9 | 3.03, br d (5.5) | 56.2 | 3.02, d (10.8) | 56.3 | 2.71, dd (12.0, 5.5) | 52.9 | 2.69, br dd(12.0, 6.5) | 53.1 | 2.35, m | 53.9 |
10 | 50.2 | 50.5 | 50.2 | 50.4 | 52.0 | |||||
11 | 5.48, m | 68.7 | 5.45, td (10.8, 5.7) | 68.8 | 1.65, m | 20.1 | 1.63, m | 20.3 | 1.70, m | 19.4 |
2.01, m | 2.05, m | 2.08, m | ||||||||
12 | 1.96, m | 33.9 | 1.96, dd (13.5, 10.8) | 34.0 | 1.34, m | 28.6 | 1.34, m | 28.8 | 1.20, m | 31.0 |
1.84, dd (13.5, 5.5) | 1.81, dd (13.5, 5.7) | 2.00, dt (14.0, 4.5) | 1.97, m | 1.90, m | ||||||
13 | 42.0 | 41.9 | 41.4 | 41.4 | 37.3 | |||||
14 | 72.9 | 72.9 | 73.3 | 73.6 | 73.4 | |||||
15 | 2.98, d (4.0), 2H | 39.4 | 2.94, d (17.9) | 39.4 | 2.93, d (18.0) | 39.3 | 2.98, d (18.0) | 39.3 | 2.81, d (18.2) | 40.6 |
3.10, d (17.9) | 2.99, d (18.0) | 3.09, d (18.0) | 3.23, d (18.2) | |||||||
16 | 168.3 | 169.3 | 168.8 | 169.0 | 170.0 | |||||
17 | 5.61, s, | 78.2 | 5.64, s | 78.2 | 5.68, s | 77.7 | 5.70, s | 77.6 | 5.74, s | 79.0 |
18 | 0.97, s, 3H | 15.7 | 0.96, s, 3H | 15.6 | 1.08, s, 3H | 16.1 | 1.08, s, 3H | 16.0 | 0.90, s, 3H | 21.1 |
19 | 1.26, s, 3H | 18.3 | 1.22, s, 3H | 18.2 | 1.15, s, 3H | 16.1 | 1.13, s, 3H | 15.9 | 1.14, s, 3H | 15.4 |
20 | 120.0 | 120.1 | 120.3 | 120.3 | 121.2 | |||||
21 | 7.85, s | 142.2 | 7.82, br s | 142.1 | 7.85, br s | 143.0 | 7.79, br s | 142.4 | 7.44, s | 141.1 |
22 | 6.63, br s | 110.0 | 6.66, br s | 110.1 | 6.49, d (1.0) | 110.1 | 6.49, d (1.5) | 110.1 | 6.40, br s | 110.2 |
23 | 7.43, br s | 142.8 | 7.41, br s | 142.7 | 7.43, t (1.0) | 142.4 | 7.41, t (1.5) | 142.9 | 7.38, br s | 143.0 |
28 | 0.77, s, 3H | 22.4 | 0.78, s, 3H | 22.4 | 0.76, s, 3H | 22.6 | 0.82, s, 3H | 22.5 | 0.82, s, 3H | 22.7 |
29 | 0.79, s, 3H | 21.6 | 0.67, s, 3H | 21.0 | 0.81, s, 3H | 20.5 | 0.74, s, 3H | 20.8 | 0.73, s, 3H | 21.8 |
30 | 5.77, dd (7.0, 2.5) | 127.4 | 6.11, dd (7.0, 2.1) | 129.2 | 5.63, dd (7.0, 1.5) | 125.9 | 5.98, dd (6.5, 1.5) | 125.9 | 6.12, dd (5.5, 2.6) | 125.3 |
7-OCH3 | 3.72, s, 3H | 52.5 | 3.65, s, 3H | 52.5 | 3.72, s, 3H | 52.3 | 3.69, s, 3H | 52.3 | 3.71, s, 3H | 52.6 |
3-OCOCH3 | 171.0 | 171.0 | ||||||||
3-OCOCH3 | 2.09, s, 3H | 20.5 | 2.08, s, 3H | 20.5 | ||||||
11-OCOCH3 | 170.8 | 170.1 | ||||||||
11-OCOCH3 | 2.07, s, 3H | 20.7 | 2.06, s. 3H | 21.6 |
Analysis of the 2D NMR spectra, especially the HMBC data, confirmed 1 to be a mexicanolide-type limonoid and allowed the assignment of most of the functional groups. The Δ8,30 double bond was fixed by the HMBC correlations (Fig. 2) from H-30 to C-9 and C-14 and from H-2 to C-1, C-8 and C-30. Correlation between H-3 and the ester carbonyl of the acetyl unit at δC 171.0 indicated the presence of an acetoxy group at C-3. Another acetoxy group was assigned at C-11 by the HMBC correlation between H-11 and the ester carbonyl of the acetyl unit at δC 170.8. The bridgehead carbon C-14 bearing a hydroxy group was observed at δC 72.9, which was correlated with H-17, H-9, and H-30 in the HMBC spectrum. Thus, the planar structure of 1 was determined as depicted in Fig. 1.
The strong cross-peaks from H-17 to H-5 and H-11 in the ROESY spectrum indicated that H-5 and H-11 were co-facial, and they were arbitrarily assigned as a β-orientation. Consequently, the ROESY correlations of H-2/Me-29, H-3/Me-29 and H-9/H-19 revealed that they were α-oriented. A high quality single-crystal of 1 was obtained, and the X-ray crystallography data (Fig. 3) confirmed that 1 was a mexicanolide-type limonoid with a Δ8,30 double bond, and the absolute configuration of 1 was also determined as 2S, 3R, 5S, 9S, 10S, 11R, 13S, 14R, 17S. Finally, the structure of 1 (khasenegasin A) was determined to be as predicted in Fig. 1.
Khasenegasin B (2) was assigned a molecular formula of C29H36O10, as established on the basis of HRESIMS at m/z 567.2200 [M + Na]+ (calcd for C29H36O10Na 567.2201). The MS and data from 1D- and 2D-NMR studies (1H, 13C, HMBC, HSQC, and ROESY) indicated that compound 2 was a deacetyl derivative of 1. Based on the coherent HMBC correlation from H-11 to the carbon resonance at 170.1, the acetoxy was determined to be located at C-11. Thus, khasenegasin B (2) was demonstrated as 3-O-deacetyl derivative of 1, and its relative configuration was as the same as that of 1 by ROESY experiment.
Khasenegasin C (3), a white, amorphous powder, had a molecular formula C29H36O9, based on its HRESIMS ion at m/z 551.2253 ([M + Na]+, C29H36O9Na, calcd 551.2252) which was 58 mass units less than that of 1. A comparison of the NMR data (Table 1) of compounds 1 and 3 showed that the acetoxy group at C-11 in 1 was not present in 3. This structural variation resulted in the resonances of H2-11, Hα-12 and H-9 of 3 being shifted upfield as compared with those of 1. The structural assignment of 3 was further confirmed via the HMBC spectrum. Therefore, the structure of khasenegasin C (3) was elucidated as shown.
Khasenegasin D (4), a white, amorphous powder, showed an [M + Na]+ ion peak at m/z 509.2149 (calcd for C27H34O8Na 509.2146), which was 42 mass units less than that of 3. Analysis of the 1H and 13C NMR data of 4 afforded a structure closely related to that of 3, with the only difference in the absence of an acetyl group at C-3, which led to the upfield-shifted H-2 and H-3 in 4. This conclusion was further confirmed by the HMBC spectrum. Thus, the structure of khasenegasin D (4) was determined as 3-O-deacetyl derivative of 3.
Khasenegasin E (5) was afforded as an amorphous solid, and its molecular formula was established as C27H34O8 by HRESIMS. It had the same skeleton as that of 4, according to the 1D-NMR spectra. When compared with compound 4, the chemical shift of H-9 in 5 shifted upfield about 0.64, C-13 in 5 shifted upfield about 4 and C-18 in 5 shifted downfield about 5 due largely to the 14-βOH. Besides, the signals of the C-8, C-10, C-12, C-15 and C-17 shifted slightly downfield. These were caused by the β-OH at C-14 leading to the approach of Me-18 and H-9, which was confirmed by the strong cross-peak from Me-18 to H-9 in the ROESY spectrum. Therefore, the structure of 5 (khasenegasin E) was established as shown in Fig. 1.
Khasenegasin F (6) was isolated as a white, amorphous powder. Its molecular formula of C27H34O8 was established by HRESIMS (m/z 509.2144, calcd for [M + Na]+ 509.2146). The NMR data of 6 were similar to those of ruageanin D,18 except for the absence of an acetyl group (δH 2.13, s; δC 171.2, 20.3; COCH3 at C-3 in ruageanin D) and the presence of a hydroxyl group at C-3 in 6. This inference was confirmed by the HMBC spectrum, in which the correlations between H-3 at δH 3.62 and C-2 at δC 78.8, C-5 at δC 40.9 proved the hydroxyl group connected to C-3. For a mexicanolide type limonoid, the fusion of rings A and B requires that OH-2 be α-oriented, which was confirmed by comparing the NMR data of 6 with compounds having the same substitution pattern for this type of limonoid.19 Thus, the structure of 6 was identified as 3-O-deacetyl derivative of ruageanin D.
Khasenegasin G (7), obtained as a white, amorphous powder, displayed a molecular formula of C29H36O10, as determined by HRESIMS at m/z 567.2196 [M + Na]+ (calcd 567.2201), which was 58 mass units more than that of 6. The NMR data (Table 2) of 7 showed close similarity to those of 6. The only structural difference between the two compounds was the presence of an additional acetoxy group (δ 2.06, 3H, s; δ 169.8, 21.6) in 7, which was located at C-11 revealed by the change of chemical shift of C-11 (δC 69.1). The proton signal at δH 5.46 (H-11, td, J = 9.5, 5.1 Hz) showed HMBC correlations with carbon signals at δC 60.0 (C-9), δC 50.1 (C-10), δC 40.0 (C-12), and δC 169.8 (OAc-11), which confirmed that C-11 was acetoxylated. The relative configuration of 7 was assigned by the ROESY experiment, in which key cross-peaks between H-17/H-5, H-5/H-11, and H-17/H-11 indicated H-11 to be β-oriented. Therefore, the structure of 7 was demonstrated as shown in Fig. 1.
Position | 6 | 7 | 8 | 9 | 10 | |||||
---|---|---|---|---|---|---|---|---|---|---|
δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | |
1 | 217.3 | 216.1 | 218.4 | 216.8 | 219.0 | |||||
2 | 78.8 | 78.7 | 3.39, m | 51.3 | 2.86, m | 56.1 | 79.8 | |||
3 | 3.62, s | 85.0 | 3.63, s | 84.7 | 3.80, d (9.5) | 76.5 | 3.80, d (4.5) | 80.1 | 3.64, s | 85.9 |
4 | 40.3 | 40.3 | 39.9 | 39.8 | 39.8 | |||||
5 | 3.25, dd (9.5, 2.2) | 40.9 | 3.30, d (10.2) | 40.2 | 3.34, d (10.5) | 41.1 | 2.89, m | 42.6 | 3.19, dd (11.0, 2.0) | 39.8 |
6 | 2.38, dd (16.7, 9.5) | 33.1 | 2.36, dd (17.0,10.2) 10.5) | 32.7 | 2.38, dd (17.0, 10.5) | 32.6 | 2.45, dd (17.0, 9.9) | 32.8 | 2.40, dd (16.0, 11.0) | 33.5 |
2.33, dd (16.7, 2.2) | 2.17, d (17.0) | 2.93, d (17.0) | 2.37, d (17.0) | 2.32, dd (16.0, 2.0) | ||||||
7 | 174.0 | 173.4 | 175.3 | 174.4 | 174.3 | |||||
8 | 136.8 | 134.5 | 137.2 | 137.4 | 133.3 | |||||
9 | 2.22, m | 57.1 | 2.55, d (9.5) | 60.0 | 2.20, d (10.5) | 64.2 | 2.20, m | 56.9 | 2.04, br d (6.0) | 51.8 |
10 | 49.9 | 50.1 | 50.1 | 49.7 | 52.9 | |||||
11 | 1.64, m | 20.6 | 5.46, td (9.5, 5.1) | 69.1 | 4.60, td (10.5, 4.0) | 65.8 | 1.63, m | 20.5 | 1.78, m | 18.7 |
2.12, qd (13.2, 4.0) | 2.02, m | 1.80, m | ||||||||
12 | 1.38, m | 34.6 | 1.33, m | 40.0 | 1.41, dd (13.5, 12.0) | 45.5 | 1.38, m | 34.6 | 1.02, dt (11.5, 3.0) | 28.4 |
1.68, m | 2.15, dd (13.5, 5.1) | 1.85, dd (13.5, 4.0) | 1.65, m | 1.80, m | ||||||
13 | 37.1 | 37.2 | 37.4 | 36.9 | 38.9 | |||||
14 | 2.26, m | 45.3 | 2.35, m | 44.7 | 2.29, d (5.5) | 45.6 | 2.23, m | 45.2 | 136.0 | |
15 | 2.95, dd (18.6,2.2) | 30.1 | 2.91, 2H, s | 30.2 | 2.89, dd (17.5, 5.5) | 30.4 | 2.92, dd (18.5,5.6) | 30.1 | 5.37, s | 66.1 |
2.90, dd (18.6,5.8) | 2.86, d (17.5) | 2.88, d (18.5) | ||||||||
16 | 169.6 | 169.3 | 169.7 | 170.0 | 175.3 | |||||
17 | 5.68, s | 77.4 | 5.61, s | 77.8 | 5.55, s | 77.4 | 5.64, s | 77.4 | 5.57, s | 81.0 |
18 | 1.09, s, 3H | 22.0 | 1.00, s, 3H | 21.7 | 1.12, s, 3H | 21.7 | 1.09, s, 3H | 22.2 | 1.05, s, 3H | 17.5 |
19 | 1.21, s, 3H | 15.8 | 1.32, s, 3H | 17.9 | 1.39, s, 3H | 18.7 | 1.14, s, 3H | 16.1 | 1.25, s, 3H | 17.1 |
20 | 120.8 | 120.7 | 120.6 | 120.8 | 120.7 | |||||
21 | 7.76, s | 142.1 | 7.78, s | 141.9 | 7.85, s | 143.2 | 7.73, s | 142.2 | 7.63, s | 142.2 |
22 | 6.46, s | 109.9 | 6.61, s | 109.8 | 6.49, s | 109.9 | 6.45, d (1.0) | 109.9 | 6.53, d (1.0) | 110.2 |
23 | 7.40, s | 143.0 | 7.40, s | 142.8 | 7.43, s | 142.3 | 7.40, t (1.0) | 143.0 | 7.40, t (1.0) | 142.9 |
28 | 0.85, s, 3H | 22.4 | 0.83, s, 3H | 22.3 | 0.84, s, 3H | 22.8 | 0.90, s, 3H | 25.7 | 0.82, s, 3H | 24.0 |
29 | 0.71, s, 3H | 20.5 | 0.69, s, 3H | 20.6 | 0.75, s, 3H | 20.8 | 0.71, s, 3H | 14.2 | 0.69, s, 3H | 19.8 |
30 | 5.59, s | 129.5 | 5.71, s | 132.4 | 5.73, d (7.5) | 126.3 | 5.86, d (7.0) | 126.2 | 1.86, d (14.5) | 45.3 |
3.93, d (14.5) | ||||||||||
7-OCH3 | 3.70, s, 3H | 52.3 | 3.68, s, 3H | 52.5 | 3.71, s, 3H | 52.2 | 3.71, s, 3H | 52.3 | 3.71, s, 3H | 52.2 |
11-OCOCH3 | 169.8 | |||||||||
11-OCOCH3 | 2.06, s, 3H | 21.6 |
Khasenegasin H (8) was obtained as a white, amorphous powder with a molecular formula of C27H34O8 (HRESIMS at m/z 509.2148 [M + Na]+, calcd 509.2146). The 1H and 13C NMR data of 8 indicated its structure to be closely related to that of swietmanin C,14 with the only difference lying in a hydroxyl group at C-11 in 8 which replaced the acetyl moiety in swietmanin C. The location of the substituent was confirmed by the HMBC spectrum, cross-peaks were observed from Me-18 (δH 1.12, s), Hα-12 (δH 1.41, dd, J = 13.5, 12.0 Hz) and Hβ −12 (δH 1.85, dd, J = 13.5, 4.0 Hz) to C-11 (δC 65.8) in 8. Accordingly, the structure of khasenegasin H (8) was established as shown.
Khasenegasin I (9), a white, amorphous powder, showed the molecular formula C27H34O7, as determined by the HRESIMS at m/z 493.2194 [M + Na]+ (calcd 493.2197). Analysis of the MS and NMR data of 9 indicated that its structure was closely related to that of 6-deoxydestigloylswietenine,20 with the only change in the relative configuration of the hydroxyl group at C-3 (α-OH in 9). This conclusion was confirmed by the ROESY cross-peaks of H-17/H-5, H-5/H-3 and H-28/H-3. Accordingly, the structure of khasenegasin I was determined as shown.
The similar electronic circular dichroism spectra of 1–9 (see S1 in ESI†) indicated that the basic skeletons of these compounds possessed consistent absolute configurations as Fig. 1.
Khasenegasin J (10), a white, amorphous powder, gave a molecular formula of C27H34O9, as established on the basis of the HRESIMS at m/z 525.2094 [M + Na]+ (calcd 525.2095). Its IR absorption bands showed the presence of hydroxyl (3447 cm−1) and carbonyl groups (1729 cm−1). The observation of proton signals for a β-substituted furan ring (δH 7.63, s, H-21; 6.53, d, J = 1.0, H-22 and 7.40, t, J = 1.0, H-23), a methoxy group (δH 3.71, 3H, s), four tertiary methyls (δH 1.05, 3H, s, Me-18; 1.25, 3H, s, Me-19; 0.82, 3H, s, Me-28 and 0.69, 3H, s, Me-29), and a characteristic low-field H-17 proton at δ 5.57 (1H, s) in the 1H NMR spectrum, as well as the characteristic carbonyl group at C-1 (δC 219.0), the olefinic resonances at C-8 (δC 133.3) and C-14 (δC 136.0) in the 13C NMR spectrum, strongly suggested that 10 was a mexicanolide-type limonoid with a Δ8,14 double bond.20 Further analysis of the spectroscopic data of 10 indicated that it was a congener of swietmanin F14 with a hydroxyl group at C-3, which was confirmed by the HMBC correlations (Fig. 4) between Hβ −30 at δH 3.93 and C-3 at δC 85.9, H-3 at δH 3.64 and C-2 at δC 79.8, H-3 at δH 3.64 and C-4 at δC 39.8. The ROESY correlations from H-17 to H-5, H-5 to Me-28, H-30β to H-15 indicated that these protons were β-oriented. Correlations between Me-19 and H-9, H-3 and H-29 revealed that they were α-oriented. Thus, the structure of khasenegasin J was proposed as shown.
Khasenegasin K (11) was afforded as a white, amorphous powder, having a molecular formula of C27H34O8, as established on the basis of HRESIMS at m/z 509.2150 [M + Na]+ (calcd 509.2146). The 1H and 13C NMR data revealed 11 to be a structural congener of 10. In the 1H NMR spectrum, the presence of an additional proton at δH 3.10 (ddd, J = 10.0, 6.0, 2.5 Hz) and H-3 at δH 3.76 (d, J = 10.0 Hz) indicated the hydroxyl group at C-2 of 10 was absent. The predication was verified by the 2D NMR spectra. Therefore, compound 11, named khasenegasin K, was established as 2-O-dehydroxylation derivative of 10 as shown in Fig. 1.
Khasenegasin L (12) was isolated as a white and amorphous powder. The molecular formula, C29H36O9, was deduced from the positive HRESIMS ion at m/z = 551.2253 ([M + Na]+, calcd for C29H36O9Na, 551.2252). The 1H and 13C NMR data (Table 3) of 12 were similar to those of fissinolide,4 a mexicanolide-type limonoid with a Δ8,14 double bond from K. senegalensis. The major difference between them was the presence of an additional hydroxyl group in compound 12. Detailed analysis of the 2D NMR spectra (HSQC and HMBC) of compound 12, especially the key HMBC cross-peaks of H-3 (δH 5.11, d, J = 10.4 Hz)/C-1′ (δC 170.3), H-30 (δH 4.92, d, J = 3.0 Hz)/C-2 (δC 56.0), C-9 (δC 47.7), C-14 (δC 135.9), indicated that the acetoxyl and hydroxyl groups were located at C-3 and C-30, respectively. The observed ROESY correlations of Me-29/H-3, Me-29/Me-19, Me-19/H-9, H-9/H-30, and H-30/H-3 revealed H-3 and H-30 to be α-oriented. Therefore, the structure of khasenegasin L (12) was finally established.
Position | 11 | 12 | 13 | 14 | ||||
---|---|---|---|---|---|---|---|---|
δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | δH (multi, J in Hz) | δC | |
1 | 219.2 | 215.4 | 217.9 | 216.0 | ||||
2 | 3.10, ddd (10.0, 6.0, 2.5) | 50.1 | 3.20, dd (10.4, 3.0) | 56.0 | 3.02, m | 49.1 | 3.07, dd (8.2, 1.6) | 58.7 |
3 | 3.76, d (10.0) | 77.4 | 5.11, d (10.4) | 77.4 | 3.88, d (8.2) | 78.7 | 3.95, d (8.2) | 77.1 |
4 | 39.5 | 39.4 | 38.3 | 39.2 | ||||
5 | 3.27, dd (11.0, 2.5) | 39.6 | 3.26, dd (9.0, 4.5) | 41.1 | 2.84, dd (8.3, 3.8) | 48.1 | 2.82, dd (8.0, 4.2) | 47.7 |
6 | 2.42, dd (16.0, 11.0) | 33.6 | 2.38, d (9.0) | 33.6 | 2.33, dd (17.4, 8.3) | 32.8 | 2.31, dd (17.5, 8.0) | 33.1 |
2.35, dd (16.0, 2.5) | 2.37, d (4.5) | 2.23, dd (17.4, 3.8) | 2.23, dd (17.5, 4.2) | |||||
7 | 174.6 | 174.3 | 174.5 | 174.3 | ||||
8 | 134.5 | 130.3 | 131.9 | 132.0 | ||||
9 | 2.07, d (7.0) | 52.1 | 2.48, m | 47.4 | 140.9 | 141.8 | ||
10 | 54.1 | 53.2 | 49.7 | 50.5 | ||||
11 | 1.75, m | 18.9 | 1.75, m | 18.8 | 1.94, m | 21.1 | 1.96, m | 21.5 |
1.81, m | 1.85, m | 2.36, m | 2.38, m | |||||
12 | 1.02, m | 28.5 | 1.14, m | 29.2 | 1.55, m | 29.7 | 1.53, m | 29.2 |
1.80, m | 1.79, m | 1.74, m | 1.64, m | |||||
13 | 38.8 | 38.6 | 40.2 | 35.5 | ||||
14 | 136.1 | 135.9 | 74.0 | 2.50, dd (11.6, 5.1) | 38.4 | |||
15 | 5.35, s | 66.1 | 3.64, dd (20.5, 3.0) | 33.0 | 3.02, d (16.6) | 39.4 | 2.97, dd (16.6, 5.1) | 32.1 |
3.80, dd (20.5, 1.5) | 2.97, d (16.6) | 2.65, dd (16.6, 11.6) | ||||||
16 | 175.5 | 169.5 | 171.4 | 173.2 | ||||
17 | 5.59, s | 81.2 | 5.69, s, | 80.6 | 5.29, s | 79.9 | 5.02, s | 81.3 |
18 | 1.04, s, 3H | 17.2 | 1.11, s, 3H | 18.2 | 0.93, s, 3H | 15.8 | 0.77, s, 3H | 20.6 |
19 | 1.16, s, 3H | 17.1 | 1.17, s, 3H | 16.9 | 1.01, s, 3H | 17.3 | 1.05, s, 3H | 17.0 |
20 | 120.7 | 120.6 | 121.3 | 121.2 | ||||
21 | 7.63, s | 142.2 | 7.57, s | 142.0 | 7.60, s | 141.2 | 7.46, br s | 141.8 |
22 | 6.53, d (1.5) | 110.2 | 6.49, d (1.0) | 110.0 | 6.50, br s | 110.2 | 6.42, br s | 110.0 |
23 | 7.40, t (1.5) | 142.9 | 7.42, br s | 143.1 | 7.43, br s | 143.4 | 7.43, br s | 143.4 |
28 | 0.82, s, 3H | 24.1 | 0.70, s, 3H | 23.3 | 1.08, s, 3H | 26.8 | 1.10, s, 3H | 26.3 |
29 | 0.75, s, 3H | 20.3 | 0.82, s, 3H | 20.6 | 0.82, s, 3H | 23.4 | 0.86, s, 3H | 24.5 |
30 | 2.22, dd (15.0, 6.0) | 34.5 | 4.92, d (3.0) | 70.6 | 3.06, d (16.8) | 31.7 | 4.87, s | 72.0 |
3.63, dd (15.0, 2.5) | 2.54, m | |||||||
7-OCH3 | 3.71, s, 3H | 52.0 | 3.71, s, 3H | 52.3 | 3.71, s, 3H | 52.3 | 3.71, s, 3H | 52.2 |
3-OCOCH3 | 170.3 | |||||||
3-OCOCH3 | 2.16, s, 3H | 21.3 |
Khasenegasin M (13) had an adduct ion peak at m/z 509.2149 [M + Na]+ in the HRESIMS spectrum. The IR spectrum implied the presence of hydroxyl and carbonyl groups with the absorption bands at 3451 and 1721 cm−1, respectively. The NMR data of 13 were similar to those of 4, except for the replacement of Δ8,30 double bond by Δ8,9 double bond. The existence of the Δ8,9 double bond was confirmed by HMBC correlations (Fig. 5) of Me-19/C-9, H2-12/C-9 and H2-15/C-8. The relative configuration of 13 was assigned by the ROESY spectrum (Fig. 5), and the hydroxyl group at C-14 was revealed to be α-oriented according to C-13 (δC 40.2), comparing with the chemical shifts of C-13 (δC 42.0, 41.9, 41.4, 41.4) in compounds 1 to 4. Therefore, the structure of 13 was established as shown.
Khasenegasin N (14) was obtained as a white, amorphous powder. It gave a molecular formula of C27H34O8 as established by an HRESIMS ion at m/z 509.2144 [M + Na]+ (calcd 509.2146). The NMR data (Table 3) of 14 showed close similarity to those of compound 13. The only structural difference between the two compounds was the location of a hydroxyl group (at C-30 in 14 and at C-14 in 13). The presence of the hydroxyl group at C-30 was confirmed by HMBC correlations from H-30 (δH 4.87, s) to C-1 (δC 216.0), and from H-2 (δH 3.07, dd, J = 8.2, 1.6 Hz), H-3 (δH 3.95, d, J = 8.2 Hz) to C-30 (δC 72.0). The relative configuration of the hydroxyl group at C-30 was β-oriented according to the ROESY correlations of Me-18/H-14 and H-14/H-30. Therefore the structure of khasenegasin N (14) was elucidated as shown.
Glutamate is known to be associated with central excitatory neurotransmission, and participates in a variety of physiological functions such as fast synaptic transmission, neuronal plasticity, learning and memory, etc. However, excessive glutamate can activate N-methyl-D-aspartate receptor (NMDAR), leading to excessive Ca2+ influx, mitochondrial function damage, reactive oxygen species (ROS) rapid accumulation, neurotoxicity, and eventually neuronal cell death. Neuronal cell damage caused by excessive glutamate may be involved in neuropsychiatric and neuropathological disorders such as ischemic stroke, traumatic brain injury, Alzheimer's disease and other neurodegenerative diseases.21,22 Some limonoids from family Rutaceae have been reported to have neuroprotective activities.23,24 Therefore these mexicanolide-type limonoids were screened for their protective effects against glutamate-induced injury in primary rat cerebellar granule neuronal cells (CGCs) along with their cytotoxicities in CGCs in this research. Cell viabilities were evaluated by MTT assay, and the cell viability in control was taken as 100%, meanwhile the average value of cell viabilities under glutamate exposure was 53.6 ± 4.7%. The values of cell viabilities (see S2 in ESI†) about their cytotoxicities test indicated that most compounds except 2, 5 and 13 had no cell toxicities in CGCs at a concentration of 10 μM, and most isolates displayed protective effects against glutamate-induced injury in CGCs at 10 μM. The superior values of cell viabilities of 6 and 17, 88.5 ± 6.4% and 78.4 ± 5.7% at 10 μM, 87.6 ± 1.2% and 76.5 ± 2.0% at 1 μM, indicated that these two compounds showed significant neuroprotective activities against glutamate-induced injury in primary rat CGCs, exhibiting similar neuroprotective activities to edaravone, a positive control with cell viability at 86.7 ± 5.6% at 50 μM (Fig. 6).
Fig. 6 MTT assay (compounds in glutamate-treated neurons). The values expressed as mean ± SD of triplicate experiments. *P < 0.05, ***P < 0.001 vs. Glu group; ###P < 0.001 vs. control group, n = 3. |
We also showed that two compounds had significant neuroprotective activities against glutamate-induced injury in CGCs at 10 μM and 1 μM. These results revealed that Khaya senegalensis contains diverse mexicanolide limonoids in structure and biological activity. Therefore, it will be interesting and valuable to pay more attention to the neuroprotective activities of the limonoids from the Meliaceae.
Further fractionation Fr. C (30.5 g) was performed on a silica gel column using a gradient of CH2Cl2–MeOH (100:1–5:1) to yield five fractions C1–5 by TLC analysis. Fraction C2 (9.2 g) was run on an ODS column using a step gradient of MeOH–H2O (30:70 to 100:0), to afford four subfractions (C2a–d). Fraction C2a (240.4 mg) was separated via semi-preparative HPLC using the mobile phase MeOH–H2O (40:60) to yield 8 (20.2 mg, retention time = 10.7 min) and 17 (40.1 mg, retention time = 17.8 min). Fraction C2b (700.4 mg) was chromatographed over a Sephadex LH-20 column, eluted with CH2Cl2–MeOH (1:1) to yield three further fractions, C2b1–3. Fraction C2b1 was separated by semi-preparative HPLC, with 65% methanol in water, to yield compounds 6 (15.2 mg, retention time = 15.1 min), 13 (3.3 mg, retention time = 23.4 min). Using the same purification procedures, fraction C2b2 yielded 9 (3.3 mg, retention time = 16.8 min) and 12 (5.1 mg, retention time = 26.5 min), and fraction C2b3 yielded 11 (4.5 mg, retention time = 14.8 min) and 16 (21.1 mg, retention time = 22.6 min). Fraction C4 (2.6 g) was subjected to an ODS column chromatography (MeOH–H2O, 40:60 to 100:0) to obtain three subfractions, C4a–c. Fraction C4c (104.0 mg) was separated on a column of Sephadex LH-20 gel to give two major components, and each of these was separated by semi-preparative HPLC with 60% methanol in water as the mobile phase to yield 2 (8.5 mg, retention time = 10.7 min), 7 (20.3 mg, retention time = 13.6 min) and 5 (4.2 mg, retention time = 17.3 min) respectively. Fraction C5 (1.6 g) was further purified by RP C18 CC (MeOH–H2O, 30:70–100:0) to afford three subfractions, C5a–c. Subfraction C5a was subjected to preparative HPLC (MeCN–H2O, 42:58) to yield compounds 4 (13.2 mg, retention time = 14.3 min). Using the same purification procedures, fraction C5b yielded 10 (4.4 mg, retention time = 18.2 min), and fraction C5c yielded 14 (2.3 mg, retention time = 26.5 min).
Footnote |
† Electronic supplementary information (ESI) available. CCDC 1044056. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra05006e |
This journal is © The Royal Society of Chemistry 2015 |